ME/CFS AUSTRALIA (SA) INC Registered Charity 698 Mailing address: GPO Box 383, Adelaide, South Australia 5001 Office: 266 Port Road, Hindmarsh, South Australia 5007 Ph: (08) 8346 3237 ('834 MECFS') Office Hours: Wednesdays, 10am-3pm Support Line: (Mondays and Thursdays, 10am-3pm) Ph: (08) 8346 3237 SA country callers: Ph: 1300 128 339 (local call)
ME/CFS Australia (SA) Inc supports the needs of sufferers of Myalgic Encephalomyelitis, Chronic Fatigue Syndrome and related illnesses. We do this by providing services and information to members.
Disclaimer ME/CFS Australia (SA) Inc aims to keep members informed of the various research projects, diets, medications, therapies etc. All communication, both verbal and written, is merely to disseminate information and not to make recommendations or directives. Unless otherwise stated, the views expressed on this Web site are not necessarily the official views of the Society or its Committee and are not simply an endorsement of products or services. |
|
|||||||||||||
Low-dose naltrexoneThursday 23 April 2009
The reports says that a “preliminary study shows that low-dose naltrexone may be an effective, low-cost treatment for Fibromyalgia.”
Elsewhere, Maija Haavisto, a Finnish ME/CFS patient, has taken low-
There’s also a website detailing low-dose naltrexone research around the world:
Even the US TV media has reported on it: Unfortunately for Australians with ME/CFS/Fibromyalgia who wish to trial it, naltrexone – low-dose or otherwise – is currently prescribed solely at the discretion of the consulting doctor. However, if further international trials strengthen the case for the use of naltrexone in people with ME/CFS/Fibromyalgia then maybe a few brave souls in Australia can start lobbying the appropriate authorities.
blog comments powered by Disqus
|
||||||||||||||